Loading…
Evonik will build a methyl mercaptan plant at its Mobile, Alabama site, an intermediate currently sourced from third parties, to produce DL-methionine. The investment is about EUR 150 million over three years, with start-up planned for the second half of 2024.
Backward integration into methyl mercaptan secures methionine supply for Americas feed buyers, a modest long-term easing of the methionine tightness, with no near-term price impact.
feedandadditive.comDerya YıldızFeb 24, 2022Not enough comparable past events yet for a historical read.
Moves of each commodity's benchmark from the last close before the event. Historical reads pool past events of the same kind; they describe what happened, not what will. Not investment advice.
